• Institute of Organ Transplantation, Sichuan Academy of Medical Sciences, Sichuan Provincial People’s Hospital, Chengdu 610072, P. R. China;
DENG Shaoping, Email: sdeng10@163.com
Export PDF Favorites Scan Get Citation

On January 7, 2022, the University of Maryland Medical Center reported that the world’s first gene-edited pig heart was successfully transplanted into a 57-year-old man with end-stage heart disease, causing a global attention. The first gene-edited pig heart transplanted into a human successfully survived for 59 d without showing early signs of rejection, creating a history of xenotransplantation and marking a key step forward the clinical development of xenotransplantation. This article focuses on the role of gene editing in alleviating immune rejection, summarizes the case of xenotransplantation at the Maryland Medical Center, and outlines the current status of xenotransplantation and the unresolved issues of xenotransplantation. It is expected that xenotransplantation can successfully enter the clinic in the near future.

Citation: LI Danni, ZHAO Yanshuang, WANG Yi, PAN Dengke, DENG Shaoping. New advances in xenotransplantation: from bench to bedside. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2022, 29(6): 705-710. doi: 10.7507/1007-9424.202204023 Copy

  • Previous Article

    Application of structured electronic medical records for pulmonary nodules in standardized training of resident physicians
  • Next Article

    Effects of centromere protein F expression on biological behavior and prognosis of non-small cell lung cancer